1999
DOI: 10.1002/(sici)1096-8652(199903)60:3<200::aid-ajh6>3.0.co;2-0
|View full text |Cite
|
Sign up to set email alerts
|

Myelodysplastic syndromes with nephrotic syndrome

Abstract: It is sometimes reported that the immunological abnormalities in myelodysplastic syndromes (MDS) induce autoimmune disease (i.e., acute systemic vasculitic syndrome, chronic cutaneous vasculitis, polyneuropathy, relapsing polychondritis, and steroid-responsive pulmonary disorders). We investigated the clinical features of patients with MDS accompanied by nephrotic syndrome. We enrolled 125 patients with MDS who were admitted between January 1979 and May 1996 in this study. The renal function was assessed based… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
24
0
3

Year Published

2001
2001
2018
2018

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(28 citation statements)
references
References 22 publications
1
24
0
3
Order By: Relevance
“…Tubule cells presumably undergo toxic injury leading to atrophy, interstitial fibrosis, and progressive kidney disease. This mechanism of kidney injury has been reported only rarely in the modern literature 812…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Tubule cells presumably undergo toxic injury leading to atrophy, interstitial fibrosis, and progressive kidney disease. This mechanism of kidney injury has been reported only rarely in the modern literature 812…”
Section: Discussionmentioning
confidence: 97%
“…The mechanism by which lysozyme induces kidney failure is incompletely understood. Filtered lysozyme appears to be a direct tubular toxin,7,8 and animal studies suggest that endocytic reabsorption of such low-molecular-weight cationic proteins as lysozyme by the proximal tubules exacerbates superimposed ischemic tubular damage 1…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This pseudonephrotic syndrome should be excluded before a diagnosis of paraneoplastic glomerulonephritis is made. Chemotherapy effectively ameliorated paraneoplastic glomerulonephritis in three patients,71,77 and a 2008 case report demonstrated mycophenolate treatment to be effective for CMML-associated membranous nephropathy 79…”
Section: Hematological Malignanciesmentioning
confidence: 99%
“…The prevalence of paraneoplastic glomerulonephritis in patients with myelodysplastic syndrome and chronic myelomonocytic leukemia (CMML), a myelodysplastic/myeloproliferative disorder , is 2% and 27%, respectively, as reported in a small series of 114 patients with myelodysplastic syndrome and 11 patients with CMML 71. Myelodysplastic syndrome is associated with autoimmunity and approximately 10% of patients with myelodysplastic syndrome have clinical autoimmune disorders 72.…”
Section: Hematological Malignanciesmentioning
confidence: 99%